ETF comparison
IBBvsIHF
Both Healthcare.
iShares Biotechnology ETF · iShares U.S. Healthcare Providers ETF
Holdings overlap
3 positions appear in both funds. Buying equal dollars of IBB and IHF would leave roughly0.1%of each dollar exposed to the same underlying securities.
Side by side
Sub-score comparison
Tracking quality isn't part of the composite — seewhat we don't scorefor why.
Cost difference
IHF is 7 bps cheaper than IBB. On a $100,000 position that's about $70/yr more in fees for IBB.
Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open thecost calculator pre-filled with IBB vs IHF.
Top shared holdings
3 shared in total| # | Holding | In IBB | In IHF | Overlap |
|---|---|---|---|---|
| 1 | Castle Biosciences, Inc. | 0.05% | 0.11% | 0.05% |
| 2 | OPKO Health, Inc. | 0.04% | 0.10% | 0.04% |
| 3 | Fulgent Genetics, Inc. | 0.03% | 0.06% | 0.03% |
Only in IBB
247 total- BlackRock Funds III11.66%
- Vertex Pharmaceuticals, Inc.8.08%
- Amgen, Inc.7.83%
- Gilead Sciences, Inc.6.84%
- Regeneron Pharmaceuticals, Inc.4.91%
- Argenx SE3.76%
- Alnylam Pharmaceuticals, Inc.3.12%
- Natera, Inc.2.89%
- Revolution Medicines, Inc.2.78%
- Biogen, Inc.2.47%
Only in IHF
58 total- UNITEDHEALTH GROUP INCORPORATED21.91%
- CVS HEALTH CORPORATION14.79%
- ELEVANCE HEALTH, INC.7.13%
- HUMANA INC.4.68%
- HCA HEALTHCARE, INC.4.49%
- CENTENE CORPORATION4.22%
- THE CIGNA GROUP4.00%
- VEEVA SYSTEMS INC.3.98%
- QUEST DIAGNOSTICS INCORPORATED3.51%
- LABCORP HOLDINGS INC.3.43%
Open IBB or IHF at a brokerage
Both funds trade commission-free at major US brokerages.
Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodologyand funding disclosure.
Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see/methodology/.
Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.